It is known that metastatic dormancy complicates the treatment of breast cancer, as surgical excision of primary tumors results in the acceleration of metastatic tumors.[qv: 47] Our findings suggest that the interference of inflammasome activation could protect BRCA1 mutant breast cancer patients from metastatic recurrence after resecting primary tumors. This evidence concerns the gene BRCA1 and breast carcinoma.